Jefferies Starts Kezer Life Sciences (KZR) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Cowen Starts Kezer Life Sciences (KZR) at Outperform
July 16, 2018 5:42 AM EDTCowen initiates coverage on Kezer Life Sciences (NASDAQ: KZR) with a Outperform rating.
Analyst Phil Nadeau comments "KZR-616 is a selective immunoproteasome inhibitor in development for autoimmunity. It is in Ph. Ib in lupus with data expected in H1:19. Proteasome... More
Wells Fargo Starts Kezer Life Sciences (KZR) at Outperform
July 16, 2018 5:25 AM EDTWells Fargo initiates coverage on Kezer Life Sciences (NASDAQ: KZR) with a Outperform rating and a price target of $30.00.
Analyst Jim Birchenough comments "Our positive rating and outlook is based on what we view as a highly leverageable platform and pipeline of novel immunoproteasome inhibitors... More
William Blair Starts Kezer Life Sciences (KZR) at Outperform
July 16, 2018 5:19 AM EDTWilliam Blair initiates coverage on Kezer Life Sciences (NASDAQ: KZR) with a Outperform rating.
For an analyst ratings summary and ratings history on Kezer Life Sciences click here. For more ratings news on Kezer Life Sciences click here.
Shares of Kezer Life Sciences closed at $15.80 yesterday.
... More